Brooks Instrument's New Mass Flow Controller Series Is Immune to Pressure and Temperature Flu...(Fluctuations The B-Series is a pressure-...)

Date:3/11/2009

Fluctuations
The B-Series is a pressure- and temperature-insensitive device. The mass flow controller actively measures line pressure and adjusts the control valve to virtually eliminate actual flow and flow signal changes as a result of pressure fluctuations. In addition, the output of every B-Series mass flow controller is characterized over the full operating temperature range of the device allowing superior measurement and control accuracy regardless of process or ambient temperature conditions.

Unique Advanced Diagnostics
The B-Series incorporates sophisticated internal self-diagnostic routines that continuously check the health of the device. In the event of a diagnostic fault, an alarm code flashes on the user interface. An easy to use service port provides additional diagnostic capability, minimizing the need to remove the mass flow controller from process service.

Visit BrooksInstrument.com for more information about the Brooks B-Series mass flow controller.
   
About Brooks Instrument
Brooks Instrument is a world-leading flow measurement and control instrument provider, with headquarters in Hatfield, PA USA, and manufacturing locations, regional sales, and service offices in the Americas, Europe, and Asia. Brooks' products include glass and metal tube variable area meters (rotameters), thermal mass flow meters and controllers,

Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved

1 GOOD

Page: 1 2 3
Related biology technology :

1. New Flexible Vacuum Controller from Varian, Inc. is Expandable and Easy to Use
2. Controllers Stem Cell Agency Audit Ignores California Agencys Built-in Flaws
3. Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets
4. Sopherion Therapeutics Secures $55 Million in Series C Funding
5. NanoBio Corporation Raises $12 Million in Series B Financing
6. Divergence Raises $11.8 Million in Series C Financing
7. Immune Targeting Systems Completes Second Tranche of Series-A Funding Bringing Total Funds Raised to More Than GBP5m
8. MODA Offers Paperless QC Micro Webinar Series on Automating Environmental Monitoring, Utility and Product Testing
9. TaiGen Biotechnology Secures 37 Million USD in Series C Round Financing
10. Intradigm Closes Final Tranche of $21.4 Million Series B Financing
11. Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels